Skip to content

An MMP12-Enriched Kupffer Cell-Associated Programme Links ATF3-Associated Immunometabolic Remodeling to Hepatic Metabolic Dysfunction and Fibrotic Communication Networks.

Oct 2026 · Food and Chemical Toxicology · pp. 116412 · 0 citations · 73 references
Medicine

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver injury, yet the cellular programmes linking metabolic stress with inflammation and fibrosis remain incompletely understood. Here, we integrated single-cell transcriptomics, regulatory network analysis, functional validation, and in vivo perturbation approaches to investigate macrophage-associated mechanisms during metabolic liver injury. We identified an MMP12-enriched Kupffer cell-associated programme that emerges under metabolic stress and exhibits distinct ATF3-associated immunometabolic characteristics. Functional modulation of ATF3 altered macrophage transcriptional states and mitochondrial metabolic properties, supporting its involvement in macrophage adaptation. Intercellular communication analysis combined with experimental validation identified CD93-associated hepatocyte responses and FLRT2-associated hepatic stellate cell activation as candidate pathways linking macrophage states with steatosis and fibrotic remodeling. Hepatic perturbation of these pathways improved metabolic and fibrosis-related phenotypes, while additional analyses defined the interpretation of AAV8-mediated effects at the hepatic pathway level rather than exclusive Kupffer cell specificity. Human liver datasets provided exploratory evidence for conservation of macrophage-associated regulatory programmes. Collectively, our findings reveal an immunometabolic framework connecting macrophage states with hepatic metabolic dysfunction and tissue remodeling, providing potential insights for precision therapeutic strategies in MASLD.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.